WebCytonics has developed a novel biologic solution for osteoarthritis, the debilitating joint disease which affects over 30M Americans 1 and 600M people worldwide 2. Now is the opportunity to invest in our first-in-class biopharmaceutical as we prepare for Phase 1 human clinical trials. INVEST NOW $2.30 share price WebCytonics is a biotechnology research and development company that specializes in developing diagnostics and therapeutics for osteoarthritis. Our flagship product was the Fibronectin-Aggrecan Complex Test (“FACT™”), which can detect cartilage damage due … Osteoarthritis (OA) is a crippling disease that is caused by the breakdown of … In all, osteoarthritis burdens our nation with human suffering, reduced quality of life, … Cytonics Corporation, headquartered in Jupiter, FL, is a biopharmaceutical … Mr. Bose has over 10 years’ experience in biotechnology research development … The present invention provides a liquid composition comprising: (a) alpha-2 … In addition to the FACT™ assay, Cytonics is developing the next generation in … We initiated a successful Phase 1/ 2 clinical trial with APIC™. Moreover, our … Cytonics has received over $15M in funding to-date, including $1.8M in grants from … Florida-based research company Cytonics has developed a method for injecting …

Cytonics’ First-In-Class Treatment for Osteoarthritis is …

WebDec 15, 2016 · Alpha 2 macroglobulin, or A2M injection therapy, uses proven scientific techniques and natural healing methods to successfully treat osteoarthritis at its source. It is used to prevent cartilage breakdown in patients, promote tissue growth and support the overall restoration of an affected joint. Contact our Vail or Denver office to find out if ... WebCytonics has already successfully commercialized a therapy for osteoarthritis. This FDA-approved medical device (the Autologous Protease Inhibitor Concentrate therapy, or “ … smart lawn mower much

A Painless Future Provides the Incentive Behind Cytonics - InvestorPlace

WebCytonics is a research and development company dedicated to discovering and developing therapeutics based on the protease inhibitor Alpha2 Macroglobulin (A2M). We are developing a number of A2M... WebAn effective treatment for Osteoarthritis would have a tremendous impact on both human well-being and the economic burden of the disease, as over $240B is spent treating Osteoarthritis per year. Cytonics discovered … WebOct 16, 2024 · Although it’s a new approach (from what I understand), Cytonics’ medical innovation that primarily helps osteoarthritis patients could also end up helping those … smart lawrence robot